165 related articles for article (PubMed ID: 27478410)
1. Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.
Borg D; Hedner C; Nodin B; Larsson A; Johnsson A; Eberhard J; Jirström K
BMC Clin Pathol; 2016; 16():13. PubMed ID: 27478410
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.
Borg D; Larsson AH; Hedner C; Nodin B; Johnsson A; Jirström K
J Transl Med; 2018 Oct; 16(1):290. PubMed ID: 30355278
[TBL] [Abstract][Full Text] [Related]
3. Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma.
Borg D; Hedner C; Gaber A; Nodin B; Fristedt R; Jirström K; Eberhard J; Johnsson A
Biomark Res; 2016; 4():10. PubMed ID: 27186374
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.
Heby M; Elebro J; Nodin B; Jirström K; Eberhard J
BMC Clin Pathol; 2015; 15():10. PubMed ID: 26028992
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
Fristedt R; Gaber A; Hedner C; Nodin B; Uhlén M; Eberhard J; Jirström K
J Transl Med; 2014 Apr; 12():83. PubMed ID: 24694107
[TBL] [Abstract][Full Text] [Related]
6. Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer.
Larsson A; Fridberg M; Gaber A; Nodin B; Levéen P; Jönsson G; Uhlén M; Birgisson H; Jirström K
BMC Cancer; 2012 Jul; 12():282. PubMed ID: 22769594
[TBL] [Abstract][Full Text] [Related]
7. Podocalyxin-like and RNA-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: a validatory study.
Boman K; Andersson G; Wennersten C; Nodin B; Ahlgren G; Jirström K
Biomark Res; 2017; 5():10. PubMed ID: 28293425
[TBL] [Abstract][Full Text] [Related]
8. High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death.
Jonsson L; Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Eberhard J; Jirström K
Biomark Res; 2014; 2():11. PubMed ID: 24963396
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin as a Prognostic Marker in Gastric Cancer.
Laitinen A; Böckelman C; Hagström J; Kokkola A; Fermér C; Nilsson O; Haglund C
PLoS One; 2015; 10(12):e0145079. PubMed ID: 26674770
[TBL] [Abstract][Full Text] [Related]
10. Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer.
Larsson AH; Lehn S; Wangefjord S; Karnevi E; Kuteeva E; Sundström M; Nodin B; Uhlén M; Eberhard J; Birgisson H; Jirström K
J Transl Med; 2016 May; 14(1):128. PubMed ID: 27160084
[TBL] [Abstract][Full Text] [Related]
11. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
Boman K; Larsson AH; Segersten U; Kuteeva E; Johannesson H; Nodin B; Eberhard J; Uhlén M; Malmström PU; Jirström K
Br J Cancer; 2013 Jun; 108(11):2321-8. PubMed ID: 23652315
[TBL] [Abstract][Full Text] [Related]
12. Podocalyxin is a marker of poor prognosis in colorectal cancer.
Kaprio T; Fermér C; Hagström J; Mustonen H; Böckelman C; Nilsson O; Haglund C
BMC Cancer; 2014 Jul; 14():493. PubMed ID: 25004863
[TBL] [Abstract][Full Text] [Related]
13. PODXL might be a new prognostic biomarker in various cancers: a meta-analysis and sequential verification with TCGA datasets.
He S; Du W; Li M; Yan M; Zheng F
BMC Cancer; 2020 Jul; 20(1):620. PubMed ID: 32615943
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
Larsson A; Johansson ME; Wangefjord S; Gaber A; Nodin B; Kucharzewska P; Welinder C; Belting M; Eberhard J; Johnsson A; Uhlén M; Jirström K
Br J Cancer; 2011 Aug; 105(5):666-72. PubMed ID: 21829192
[TBL] [Abstract][Full Text] [Related]
15. Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases.
Larsson AH; Nodin B; Syk I; Palmquist I; Uhlén M; Eberhard J; Jirström K
Diagn Pathol; 2013 Jul; 8():109. PubMed ID: 23819542
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis.
Wang J; Zhao Y; Qi R; Zhu X; Huang C; Cheng S; Wang S; Qi X
Oncotarget; 2017 Aug; 8(32):52457-52464. PubMed ID: 28881743
[TBL] [Abstract][Full Text] [Related]
17. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
18. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer.
Zhang J; Zhu Z; Wu H; Yu Z; Rong Z; Luo Z; Xu Y; Huang K; Qiu Z; Huang C
Gastric Cancer; 2019 Jan; 22(1):48-59. PubMed ID: 29748877
[TBL] [Abstract][Full Text] [Related]
19. 47-mG
Kaneko MK; Itai S; Yamada S; Kato Y
Monoclon Antib Immunodiagn Immunother; 2018 Jun; 37(3):158-161. PubMed ID: 29630446
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer.
Forse CL; Yilmaz YE; Pinnaduwage D; O'Malley FP; Mulligan AM; Bull SB; Andrulis IL
Breast Cancer Res Treat; 2013 Feb; 137(3):709-19. PubMed ID: 23288345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
